Papers by Keyword: Aspirin

Paper TitlePage

Authors: Nisreen Abdul Rahman Najem Abed, Suha Mujahed Abudoleh, Iyad Daoud Alshawabkeh, Abdul Rahman Najem Abed, Rasha Khaled Ali Abuthawabeh, Samer Hasan Hussein-Al-Ali
Abstract: Zinc layered hydroxides (ZLHs) can be used as host materials for drug-ZLH host–guest structures. Aspirin with 0.1 and 0.4 M were intercalated into zinc layered hydroxides to form aspirin nanocomposites; ASPN1 and ASPN4, respectively. From XRD and software, the interlayer spacing of ASPN1 and ASPN4 was 15.2 Å. The result coupled with molecular geometry calculation indicates that the spatial orientation of the drug in the ZLH was monolayer for ASPN1 and ASPN4 nanocomposites. The release of the aspirin from ASPN4 nanocomposite at pH 6.8 is 35%, compared to 98% at pH 1.2, and followed Hixson model and Korsmeyer model for ASPN4 at pH 6.8 and pH 1.2, respectively. This result indicates sustained release of the drugs from their respective nanocomposites, and therefore these nanocomposites have good potential to be used as controlled-release formulation of the aspirin. The ASPN4 nanocomposite was highly effective to Escherichia coli compared to free aspirin, where the ASPN4 given 1.37 inhibition zone compared to aspirin which given 1.17 cm inhibition zone.
Authors: Xiang Qun Xu, Nian Hong, Jing Wen Zheng, Bing Bing Guo, Lin Cheng
Abstract: To study the process conditions for preparing aspirin β-cyclodextrin inclusion.Method: Choose the usage ration of aspirin with β-cyclodextrin and the time of reaction as the main factors, and use the inclusion yield as evaluated indicators and the process condition to conduct orthogonal experiment Optimization Pack aspirin.Outcome: The optimum inclusion process condition: molar ratio of the aspirin with β-cyclodextrin is 1:3, inclusion time is 60 minutes.Conclusion: The process condition of using β-cyclodextrin inclusion to inconcluse aspirin is feasible, effective, and of applicative value.
Authors: Ya Kai Feng, Shi Feng Zhang, Li Zhang, Jin Tang Guo, Yong Shen Xu
Abstract: In this paper, the release of model drug aspirin (ASP) from biodegradable polyesterurethane networks was studied. Poly(D,L-lactide-co-glycolide)urethane (PULG) networks were prepared from hydroxyl telechelic star-shaped oligo(D,L-lactide-co-glycolide) coupled with 1,6-diisocyanate-2,2,4-trimethylhexane and 1,6-diisocyanate-2,4,4-trimethylhexane or isophorone diisocyanate. PULG networks turned from transparent to opaque after ASP loading. PULG networks with lower crosslinking density always resulted in higher drug loaded content. The results of differential scanning calorimetry (DSC) and scanning electron microscope (SEM) measurements demonstrated that ASP was uniformly distributed in the networks. The drug release courses of ASP from PULG networks in phosphate buffered saline pH = 7.0 at 37 °C could be divided into three stages. Firstly, ASP release was at approximately uniform rate from PULG networks; Secondly, the release rate obviously increased for the degradation of the PULG networks; Thirdly, the release rate decreased gradually because most of the ASP had diffused out of the PULG networks. The crosslinking density of polyesterurethane networks also affected drug release rate. The in vitro release test revealed that ASP accelerated the degradation process of PULG, which exhibited a typical erosion-controlled release mechanism.
Authors: Yan Hong Lei
Abstract: A selective method was developed for the determination of aspirin by Spectrophotometric method .The spectra (range: λ=200~320 nm) were processed. The linear ranges of aspirin was at 50.28 ~ 125.7μg • mL-1 .the aspirin showed good linear correlation.The ultraviolet spectrophotometry data of the samples were also used to evaluate the samples’ quantitative composition.It was shown that recovery of the method by standard addition method was respectively valued 102.06% for aspirin .The method was simple,reliable,accurate,reproducible with high sensitivity and selectivity.
Showing 1 to 4 of 4 Paper Titles